PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 160 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2017. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $270,000 | -60.8% | 6,962 | -53.7% | 0.38% | -41.9% |
| Q3 2018 | $689,000 | +32.8% | 15,035 | +71.4% | 0.64% | +35.5% |
| Q2 2018 | $519,000 | +6.6% | 8,771 | +22.6% | 0.48% | -6.7% |
| Q1 2018 | $487,000 | +8.2% | 7,157 | +57.1% | 0.51% | +10.9% |
| Q4 2017 | $450,000 | -8.0% | 4,555 | +11.6% | 0.46% | -23.2% |
| Q3 2017 | $489,000 | +134.0% | 4,083 | +70.6% | 0.60% | +89.6% |
| Q2 2017 | $209,000 | – | 2,393 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |